Retatrutide (“Triple G”) Weight-Loss Program

Retatrutide targets three hunger-regulating hormones—GLP-1, GIP, and glucagon—for results up to 28 % faster than current GLP-1s. Now in Phase-3 trials, we offer off-label access under strict physician oversight.

Key advantages

• Mean 17.5 % body-weight reduction at 24 weeks
• Repairs fatty-liver markers
• Weekly self-injection; lifestyle coaching included

Join the Retatrutide Early-Access List → Schedule Appointment